Assistant Professor, Medicine, Georgetown University School of Medicine
Hematology
Dr. Michael J. Pishvaian, MD
|
|
Give Review
Dr. Michael J. Pishvaian is an expert in the field of Hematology. He studied medicine at Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael J. Pishvaian, MD is also published. He has 25 publications published. The lastest publication: "Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.' He accepts Medicare.
Publications
- Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic Cancer.
- Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular Carcinoma.
- Cyclin-Dependent Kinase Inhibitors and the Treatment of Gastrointestinal Cancers.
- A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor Malignancies.
- Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer.
- A phase I study of oral ixabepilone in patients with advanced solid Tumors.
- Targeting the BRCA1/2 Tumor Suppressors.
- A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor Malignancies.
- Future of targeted agents in metastatic coloRectal cancer.
- Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular Cancer.
- Current management of inflammatory bowel disease and coloRectal cancer.
- Molecularly targeted therapy for metastatic colon Cancer: proven treatments and promising new agents.
- Phase I dose finding studies of obatoclax (GX15-070), a small molecule pan-BCL-2 family antagonist, in patients with advanced solid Tumors or lymphoma.
- Small bowel adenoCarcinoma.
- Liver stem cells and molecular signaling pathways in hepatocellular Carcinoma.
- The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated Carcinoma cell differentiation and proliferation.
- Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways.
- A phase I trial of bexarotene in combination with docetaxel in patients with advanced solid Tumors.
- Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.
- Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular Cancer through cyclin D1 activation.
- Biomarkers of WNT signaling.
- Cadherin-11 is expressed in invasive breast Cancer cell lines.
- Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo Chemoradiation.
- Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic Cancer.
Schools
Georgetown University
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Georgetown University Hospital -
Georgetown University School of Medicine
Hospital
-
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1710171061 | |
| NPPES Provider LastName | PISHVAIAN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Hematology | |
| Total Claim Count | 225.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 66.0 | |
| Percent Opioid Claims | 29.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710171061 |
| Last Name Of The Provider | PISHVAIAN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Benjamin A. Weinberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis M. Weiner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert D. Warren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Metin Ozdemirli, MD |
|
|
Dr. Susan L. Honig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrianne P. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aiwu R. He, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas C. Havell II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Channing Paller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman J. Martin, MD
This Doctor is OpenDoctor Recommended.
|